Home › Funds › Merck & Co., Inc. › HURA

Merck & Co., Inc. position in HURA

TUHURA BIOSCIENCES · Health Care

Merck & Co., Inc. reported holding 19,445 shares of HURA (TUHURA BIOSCIENCES) in its Q3 2026 13F filing — a position valued at US$41K, representing 0.00% of its reported portfolio and ranking #12 among its reported holdings. Merck & Co., Inc. has disclosed HURA holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)19.45K sh
Reported value held$40.83K
Portfolio Weight0.00%
First reportedQ2 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Merck & Co., Inc.'s HURA position evolved

Merck & Co., Inc. first disclosed a stake in HURA in Q2 2025 at 13,950 shares (US$31K). The position peaked in Q2 2026 at 19,445 shares, worth US$46K. Across 6 filings, Merck & Co., Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 19,445 shares valued at US$41K. Notable position changes include a 39% increase in Q1 2026 (shares rose 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 13.95K $31.11K New
Q3 2025 13.95K $34.60K Hold
Q4 2025 13.95K $10.56K Hold
Q1 2026 19.45K $34.81K Add
Q2 2026 19.45K $45.50K Hold
Q3 2026 19.45K $40.83K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HURA and 13F data

HURA (TUHURA BIOSCIENCES) is a Health Care company. 63 other funds we track also report a position in HURA. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HURA

No other tracked fund reports a position in HURA.

All HURA fund holders →

FAQ

How long has Merck & Co., Inc. held HURA?

Merck & Co., Inc. has disclosed HURA holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Merck & Co., Inc.'s current position in HURA?

As of Q3 2026, Merck & Co., Inc. holds 19.45K shares of HURA (TUHURA BIOSCIENCES), valued at $40.83K, representing 0.00% of its reported portfolio and ranking #12.

Has Merck & Co., Inc. been buying or selling HURA?

In the latest 13F filing (Q3 2026), Merck & Co., Inc. held unchanged its position in HURA. The position peaked in Q2 2026 at 19.45K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.